Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 14, 2006Journal of Clinical Oncology

Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective Study

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJeanne A. PetrekMemorial Sloan Kettering Cancer CenterMNMichelle J. NaughtonThe Ohio State UniversityLCL. Douglas CaseUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Petrek et al. (2006) studied this question.

synapsesocial.com/papers/6a027d27f57c648cc201d5f4https://doi.org/10.1200/jco.2005.03.3969
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.1998 · 624 citations
  2. 2Risk of Menopause During the First Year After Breast Cancer Diagnosis1999 · 605 citations
  3. 3Ovarian Ablation as Adjuvant Therapy for Breast Cancer2001 · 44 citations
  4. 4Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up1995 · 1,056 citations
  5. 5Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study2002 · 341 citations